SCHIZOPHRENIA
Clinical trials for SCHIZOPHRENIA explained in plain language.
Never miss a new study
Get alerted when new SCHIZOPHRENIA trials appear
Sign up with your email to follow new studies for SCHIZOPHRENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Eye scan could reveal best drug for schizophrenia
Disease control TerminatedThis study tested whether a non-invasive scan of the eye's blood vessels could predict which patients with early schizophrenia would respond to an intravenous drug called sodium nitroprusside. The drug was given to help reduce symptoms of psychosis and improve thinking. The goal …
Matched conditions: SCHIZOPHRENIA
Phase: PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated Apr 02, 2026 03:41 UTC
-
Study links mental health drugs to heart risk - tests solutions
Disease control TerminatedThis study looked at heart disease risk in people taking medications for schizophrenia, schizoaffective disorder, or bipolar disorder. Researchers measured blood fats and heart electrical patterns to identify those at highest risk. They then tested whether changing medications, i…
Matched conditions: SCHIZOPHRENIA
Phase: PHASE3 • Sponsor: Northwestern University • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Can better dental care improve life for schizophrenia patients?
Disease control TerminatedThis study tested whether a 6-month dental health education program could improve oral hygiene and quality of life for people with schizophrenia. The program taught patients about dental care and was compared to standard monitoring. Researchers followed 79 patients for 12 months …
Matched conditions: SCHIZOPHRENIA
Phase: NA • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New approach tests injection plus training for schizophrenia recovery
Disease control TerminatedThis study tested whether combining long-acting antipsychotic injections with cognitive and functional skills training could help people with early schizophrenia achieve lasting symptom relief and better daily functioning. It aimed to see if this comprehensive approach could lead…
Matched conditions: SCHIZOPHRENIA
Phase: PHASE4 • Sponsor: University of Miami • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Schizophrenia drug trial halted early after testing in asia
Disease control TerminatedThis study tested how safe and effective the medication cariprazine is for treating adults with schizophrenia in Japan and Taiwan. The trial was designed to last 6 months but was stopped early after enrolling only 34 participants. Researchers compared the drug against a placebo t…
Matched conditions: SCHIZOPHRENIA
Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
New app aims to help veterans at risk of suicide by teaching them to recognize their feelings
Symptom relief TerminatedThis study tested a new program for veterans with serious mental illness who are at risk of suicide. The program combined weekly group education with a smartphone app designed to help people better recognize and understand their own emotions, a skill linked to lower suicide risk.…
Matched conditions: SCHIZOPHRENIA
Phase: PHASE1 • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Apr 02, 2026 03:41 UTC
-
Brain scans may predict who benefits from 'Social Hormone' for schizophrenia
Symptom relief TerminatedThis study tested whether oxytocin, a hormone involved in social bonding, could help improve social functioning in veterans with schizophrenia. Researchers used brain scans to see how oxytocin affected brain activity and tried to predict which individuals might benefit from a thr…
Matched conditions: SCHIZOPHRENIA
Phase: PHASE2 • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Mar 30, 2026 14:35 UTC
-
Online hub tested to help young adults with psychosis feel less alone
Knowledge-focused TerminatedThis study looked at how well a digital platform called Horyzons could be added to regular mental health care. Horyzons offers therapy content and a private social network. Researchers worked with clinics in North Carolina to understand what helps or hinders using the platform. T…
Matched conditions: SCHIZOPHRENIA
Phase: NA • Sponsor: University of North Carolina, Chapel Hill • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC